0001104659-14-087784.txt : 20141219 0001104659-14-087784.hdr.sgml : 20141219 20141219102005 ACCESSION NUMBER: 0001104659-14-087784 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141217 FILED AS OF DATE: 20141219 DATE AS OF CHANGE: 20141219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rogus Joseph J CENTRAL INDEX KEY: 0001299691 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 141297857 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE STREET 2: 3RD FLOOR CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 a4.xml 4 X0306 4 2014-12-17 0 0000890465 NPS PHARMACEUTICALS INC NPSP 0001299691 Rogus Joseph J 550 HILLS DRIVE BEDMINSTER NJ 07921 0 1 0 0 SVP Gbl Tech Oper Sup Chn Mgt Common Stock 2014-12-17 4 M 0 5175 5.05 A 25326 D Common Stock 2014-12-17 4 M 0 11292 3.34 A 36618 D Common Stock 2014-12-17 4 S 0 16467 35.00 D 20151 D Employee Stock Options (right to buy) 5.05 2014-12-17 4 M 0 5175 0 D 2018-07-15 Common Stock 5175 0 D Employee Stock Options (right to buy) 3.34 2014-12-17 4 M 0 11292 0 D 2020-02-19 Common Stock 26782 74051 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. On July 15, 2008, the reporting person received a grant of 5,175 stock options under NPS Pharmaceuticals, Inc.'s (the "Issuer") 1998 Stock Option Plan. The options became exercisable based on the following vesting schedule: 28% on the first anniversary of the grant and 2% each month thereafter. As of the date of this filing, all 5,175 stock options have vested. On February 19, 2010, the reporting person was granted options to purchase shares of common stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. As of the date of this filing, the performance criteria and the time-based criteria for 112,125 of these options has been satisfied. These options vested and became exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant. /s/ Joseph J. Rogus, by Jill Thompson as attorney-in-fact 2014-12-18